When the ASC final rule was published I found I had questions regarding the payment indicators. I have researched all the materials I can find to identify the reimbursement associated with each indicator. In the final rule, Addendum DD1 lists the indicators, ex: F4-which states Corneal tissue acquisition; paid at reasonable cost" How do we find out what the reasonable cost is? OR is their an equation used to determine for each locality.
You may contact me directly at Jan.Gerald@healthalliance.org
You may contact me directly at Jan.Gerald@healthalliance.org